FDA to look at MediSpectra's cervical imaging PMA (pre-market approval)
This article was originally published in Clinica
Executive Summary
MediSpectra, of Lexington, Massachusetts, is scheduled to go before an FDA advisory committee on May 17 to discuss the pre-market approval (PMA) application for its Luma Cervical Imaging System.